Among patients with DLBCL receiving first-line therapy in 2014-2021, 10% of those exposed to opioids developed new persistent ...

High levels of adolescent vaccination coverage continued through 2025, but study authors recognize a need for further and more consistent coverage.

Women are significantly underrepresented in clinical trials for PTSD, particularly in studies evaluating pharmacotherapies.

The FDA granted Breakthrough Therapy designation to DT120 (lysergide ODT) for major depressive disorder based on positive phase 3 Emerge trial findings.

The AAP Committee on Infectious Diseases provides an updated set of recommendations for RSV vaccination among infants and children.

GLP-1 RA prescriptions for children aged 8 to 11 years without diabetes, but with obesity, have been rising between 2019 and ...

Risk for all-cause dementia associated with smoking exposure is significantly higher in APOE ε4 noncarriers vs APOE ε4 carriers.

Black vs White youths and young adults receive fewer psychotropic medications in the year before a schizophrenia or MDD diagnosis.

Apolipoprotein E ε4 status does not alter the relationship between neighborhood disadvantage and plasma markers of neurodegeneration.

Higher pain intensity in nursing home residents with dementia is associated with a greater number of symptoms linked to caregiver burden.

Teenagers and young adults could be discouraged from using social media if health warnings and similar labels were applied to platforms.

There is a significantly higher risk for opioid-related harmful outcomes associated with fentanyl from illicit sources vs medical sources.